Abstract
Little is known about how engagement with healthcare providers mediates the relationship between psychosocial factors (anxiety, depression, stigma) and medication adherence among persons living with HIV (PLWH). Moreover, little research has investigated potential biological sex differences in this relationship. We conducted a secondary analysis of data collected from four projects (N = 281) focused on improving health outcomes in PLWH. Males displayed (a) negative association between depression and engagement with healthcare providers (β = − 0.02, z = − 3.20, p = 0.001) and (b) positive association between engagement with healthcare providers and medication adherence (β = 0.55, OR = 1.73, z = 2.62, p = 0.009). Females showed no association between any of these factors. Anxiety and stigma were not significantly associated with medication adherence. Path analysis modeling for males had a very good fit (CFI = 1, TLI = 1, RMSEA = 0); none of the regression coefficients was significant for females. The significant relationship between depression and medication adherence among males was fully mediated by engagement with healthcare providers. Findings suggest that adherence interventions for PLWH should be tailored by biological sex.
Résumé
Poco se sabe cómo la interacción con proveedores médicos funciona en la relación entre factores psicosociales (ansiedad, depresión, estigma) y adherencia a medicamentos en personas viviendo con VIH (PVV). Además, pocos estudios han investigado posibles diferencias en el sexo biológico en estas relacione. Dirigimos un análisis secundario de cuatro proyectos (N = 281) enfocados en PVV. Hombres demostraron (a) una asociación negativa entre depresión e interacción con proveedores médicos (β = -0.02, z = -3.20, p = 0.001) y (b) una asociación positive entre interacción con proveedores médicos y adherencia a medicamentos (β = 0.55, OR = 1.73, z = 2.62, p = 0.009). Mujeres no demostraron asociación entre estos factores. Ansiedad y estigma no fueron asociados significativamente con la adherencia a medicamentos. El modelo de análisis del camino para hombres tuvo un muy ajuste (CFI = 1, TLI = 1, RMSEA = 0); ninguna de los coeficientes de regresión fue significativa para mujeres. La relación significativa entre depresión y adherencia a medicamentos para hombres fue completamente mediada por la interacción con proveedores médicos. Las recomendaciones sugieren que las intervenciones de adherencia para PVV deberían ser ajustado por sexo biológico.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10461-020-02823-3/MediaObjects/10461_2020_2823_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10461-020-02823-3/MediaObjects/10461_2020_2823_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10461-020-02823-3/MediaObjects/10461_2020_2823_Fig3_HTML.png)
Similar content being viewed by others
References
Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health. 2016;1(4):e000125.
Selik RM, Lindegren ML. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J. 2003;22(7):635–41.
Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–33.
Centers for Disease Control and Prevention. More people with HIV have the virus under control. 2017. https://www.cdc.gov/nchhstp/newsroom/2017/2017-HIV-Continuum-Press-Release.html. Accessed 27 July 2017
Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdottir TB, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142.
Mitchell MM, Nguyen TQ, Maragh-Bass AC, Isenberg SR, Beach MC, Knowlton AR. Patient–provider engagement and chronic pain in drug-using, primarily african american persons living with HIV/AIDS. AIDS Behav. 2017;21(6):1768–74.
Bakken S, Holzemer WL, Brown MA, Powell-Cope GM, Turner JG, Inouye J, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDs. 2000;14(4):189–97.
Chen WT, Wantland D, Reid P, Corless IB, Eller LS, Iipinge S, et al. Engagement with health care providers affects self-efficacy, self-esteem, medication adherence and quality of life in people living with HIV. J AIDS Clin Res. 2013;4(11):256.
Bankoff SM, McCullough MB, Pantalone DW. Patient–provider relationship predicts mental and physical health indicators for HIV-positive men who have sex with men. J Health Psychol. 2013;18(6):762–72.
Huang L, Li L, Zhang Y, Li H, Li X, Wang H. Self-efficacy, medication adherence, and quality of life among people living with HIV in Hunan Province of China: a questionnaire survey. J Assoc Nurses AIDS Care. 2013;24(2):145–53.
Schnall R, Jia H, Olender S, Gradilla M, Reame N. In people living with HIV (PLWH), menopause (natural or surgical) contributes to the greater symptom burden in women: results from an online US survey. Menopause. 2018;25(7):744–52.
Scully EP. Sex differences in HIV infection. Curr HIV/AIDS Rep. 2018;15(2):136–46.
World Health Organization. 2019. https://www.who.int/genomics/gender/en/.
Neil RC. Psychology: the science of behaviour. London: Pearson; 2010.
Puskas CM, Forrest JI, Parashar S, Salters KA, Cescon AM, Kaida A, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep. 2011;8(4):277–87.
Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Women Health. 2002;23(2):112–9.
Turmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet. 2003;82(3):411–8.
Beauchemin M, Gradilla M, Baik D, Cho H, Schnall R. A multi-step usability evaluation of a self-management app to support medication adherence in persons living with HIV. Int J Med Inform. 2019;122:37–44.
ClinicalTrial.gov. The wise app trial for improving health outcomes in PLWH (WiseApp). Identifier NCT03205982. 2018. https://clinicaltrials.gov/ct2/show/NCT03205982.
ClinicalTrials.gov. Video information provider for HIV-associated non-AIDS (VIP-HANA) symptoms (VIP-HANA). Identifier NCT03205982. 2019. https://clinicaltrials.gov/ct2/show/NCT03182738.
Schnall R, Liu J, Mohr DC, Bakken S, Hirshfield S, Siegel K, et al. Multi-modal methodology for adapting digital health tools to new populations: adaptation of the video information provider (VIP) for persons living with HIV with HIV-associated non-AIDS (HANA) conditions. Stud Health Technol Inform. 2019;264:1347–51.
Schnall R, Jia H, Reame N. Association between HIV symptom burden and inflammatory cytokines: an analysis by sex and menopause stage. J Women Health. 2019;29(1):119–27.
Schnall R, Liu J, Reame N. Ecological momentary assessment of HIV versus reproductive health symptoms in women of differing reproductive stages living with HIV. Menopause. 2019;26(12):1375–84.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–29.
PROMIS. A brief guide to the PROMIS depression instruments. 2017. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Depression_Scoring_Manual_02222017.pdf.
PROMIS. A brief guide to the PROMIS anxiety instruments. 2019. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Anxiety_Scoring_Manual.pdf.
Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006;18(7):853–61.
Reinius M, Rao D, Manhart LE, Wiklander M, Svedhem V, Pryor J, et al. Differential item functioning for items in Berger's HIV stigma scale: an analysis of cohorts from the Indian, Swedish, and US contexts. Qual Life Res. 2018;27(6):1647–59.
Wright K, Naar-King S, Lam P, Templin T, Frey M. Stigma scale revised: reliability and validity of a brief measure of stigma for HIV+ youth. J Adolesc Health. 2007;40(1):96–8.
HealthMeasures. PROMIS overview.2019. www.nihpromis.org/about/overview.
Schnall R, Liu J, Cho H, Hirshfield S, Siegel K, Olender S. A health-related quality-of-life measure for use in patients with HIV: a validation study. AIDS Patient Care STDs. 2017;31(2):43–8.
R Development Core Team. R: a language and environment for statistical computing. Vienna: R Development Core Team; 2006.
Taber KS. The use of Cronbach’s alpha when developing and reporting research instruments in science education. Res Sci Educ. 2018;48(6):1273–96.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.
Hopper D, Coughlan J, Mullen MR. Structural equation modeling: guidelines for determining model fit. Electron J Bus Res Methods. 2008;6:53–60.
Tovar E, Rayens MK, Gokun Y, Clark M. Mediators of adherence among adults with comorbid diabetes and depression: The role of self-efficacy and social support. J Health Psychol. 2015;20(11):1405–15.
Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40(4):219–21.
Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J family Pract. 2000;49(2):147–52.
Redondo-Sendino A, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6:155.
Sohler NL, Li X, Cunningham CO. Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDs. 2009;23(9):775–83.
Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248–57.
Clayton JA. Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol Behav. 2018;187:2–5.
National Institutes of Health. Consideration of sex as a biological variable in NIH-funded research. 2015. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html.
Acknowledgements
This study was funded by the Agency for Healthcare Research and Quality (R01HS025071), the National Institute of Nursing Research of the National Institute of Health (R01NR015737, R01NR015737-02S1, and K24NR018621). DB was funded by the Reducing Health Disparities through Informatics (RHeaDI) training grant funded by the National Institute of Nursing Research (T32 NR007969). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Agency for Healthcare Research and Quality.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data organization, and data analysis were performed by DB, RS, and JL. The first draft of the manuscript was written by DB and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Baik, D., Liu, J., Cho, H. et al. Factors Related to Biological Sex Differences in Engagement with Healthcare Providers in Persons Living with HIV. AIDS Behav 24, 2656–2665 (2020). https://doi.org/10.1007/s10461-020-02823-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-020-02823-3